These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29865170)

  • 41. Pharmacotherapeutic management of breakthrough pain in patients with chronic persistent pain.
    Fishbain DA
    Am J Manag Care; 2008 May; 14(5 Suppl 1):S123-8. PubMed ID: 18611100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breakthrough pain in opioid-treated chronic non-malignant pain patients referred to a multidisciplinary pain centre: a preliminary study.
    Højsted J; Nielsen PR; Eriksen J; Hansen OB; Sjøgren P
    Acta Anaesthesiol Scand; 2006 Nov; 50(10):1290-6. PubMed ID: 16999839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial.
    Mercadante S; Radbruch L; Davies A; Poulain P; Sitte T; Perkins P; Colberg T; Camba MA
    Curr Med Res Opin; 2009 Nov; 25(11):2805-15. PubMed ID: 19792837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development, validation and psychometric properties of a diagnostic/prognostic tool for breakthrough pain in mixed chronic-pain patients.
    Samolsky Dekel BG; Remondini F; Gori A; Vasarri A; Di Nino G; Melotti RM
    Clin Neurol Neurosurg; 2016 Feb; 141():23-9. PubMed ID: 26731461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
    Portenoy RK; Taylor D; Messina J; Tremmel L
    Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study.
    Carr DB; Goudas LC; Denman WT; Brookoff D; Staats PS; Brennen L; Green G; Albin R; Hamilton D; Rogers MC; Firestone L; Lavin PT; Mermelstein F
    Pain; 2004 Mar; 108(1-2):17-27. PubMed ID: 15109503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of low doses of a sublingual fentanyl formulation for breakthrough pain in patients receiving low doses of opioids.
    Mercadante S; Adile C; Cuomo A; Aielli F; Marinangeli F; Casuccio A
    Support Care Cancer; 2017 Feb; 25(2):645-649. PubMed ID: 27744534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the quality of care of elderly patients with chronic and breakthrough pain treated with opioids: SAND study.
    Rodríguez MJ; de la Torre R; Ortega JL; Trinidad JM; Benítez D; Jiménez AJ; Sanz-Yagüe A; Soler B; Torres LM
    Curr Med Res Opin; 2018 Apr; 34(4):701-709. PubMed ID: 28914555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mediation of Movement-Induced Breakthrough Cancer Pain by IB4-Binding Nociceptors in Rats.
    Havelin J; Imbert I; Sukhtankar D; Remeniuk B; Pelletier I; Gentry J; Okun A; Tiutan T; Porreca F; King TE
    J Neurosci; 2017 May; 37(20):5111-5122. PubMed ID: 28438966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recognition and diagnosis of breakthrough pain.
    Payne R
    Pain Med; 2007; 8 Suppl 1():S3-7. PubMed ID: 17280600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of breakthrough pain in cancer patients].
    Magdelijns FJ; van den Beuken-van Everdingen MH; Courtens AM; Janssen DJ
    Ned Tijdschr Geneeskd; 2015; 159():A8121. PubMed ID: 25563780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breakthrough Pain in Patients with Lung Cancer. A Secondary Analysis of IOPS MS Study.
    Mercadante S; Masedu F; Valenti M; Aielli F
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32375331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy.
    Mazzola R; Ricchetti F; Fiorentino A; Giaj-Levra N; Fersino S; Tebano U; Albanese S; Gori S; Alongi F
    Clin Transl Oncol; 2017 May; 19(5):593-598. PubMed ID: 27853984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrasound-Guided Radiofrequency Treatment of Intercostal Nerves for the Prevention of Incidental Pain Arising Due to Rib Metastasis.
    Ahmed A; Bhatnagar S; Khurana D; Joshi S; Thulkar S
    Am J Hosp Palliat Care; 2017 Mar; 34(2):115-124. PubMed ID: 26656033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A review of the pharmacokinetic profile of transmucosal fentanyl formulations.
    Moore N; Darwish M; Amores X; Schneid H
    Curr Med Res Opin; 2012 Nov; 28(11):1781-90. PubMed ID: 23020252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pharmacoeconomics of breakthrough cancer pain.
    Kuo KL; Saokaew S; Stenehjem DD
    J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):167-75. PubMed ID: 23688496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
    Brogan SE; Winter NB; Okifuji A
    Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of sublingual fentanyl tablets for the management of breakthrough pain in patients with chronic musculoskeletal pain with neuropathic component: multicenter prospective study.
    Cánovas-Martínez L; Carceller-Ruiz JJ; Díaz-Parada P; Illodo-Miramontes G; Freire-Vila E; De la Iglesia-López A; Iglesias BG; López-Ulloa B; Domínguez-Suárez E; Camba-Rodríguez A
    Clin Drug Investig; 2015 Mar; 35(3):169-77. PubMed ID: 25655006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Procedural Pain in Palliative Care: Is It Breakthrough Pain? A Multicenter National Prospective Study to Assess Prevalence, Intensity, and Treatment of Procedure-related Pain in Patients With Advanced Disease.
    Magnani C; Giannarelli D; Casale G
    Clin J Pain; 2017 Aug; 33(8):707-714. PubMed ID: 27768607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes.
    Webster LR; Slevin KA; Narayana A; Earl CQ; Yang R
    Pain Med; 2013 Sep; 14(9):1332-45. PubMed ID: 23855816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.